Investment
Features
FeesSafety
Academy
More
Pluang+

Terraform Power shareholders approve $83.75M settlement in merger lawsuit with Brookfield affiliates

Market News
05 May 2026
PRNewsWire
View Source
Neutral
pluang ai news

Shareholders of Terraform Power, Inc. have been notified of a proposed $83.75 million cash settlement resolving a class action lawsuit related to the company's 2020 merger with Brookfield affiliates. The settlement, if approved by the Delaware Court of Chancery on June 22, 2026, will end all claims against Brookfield and related defendants. Eligible shareholders who exchanged Terraform shares for Brookfield shares or partnership units will receive pro rata payments from the settlement fund without needing to file claims. The court hearing will also address class certification, legal fees, and any objections to the settlement plan.

More News

T3 Defense surges 201% on tech expansion; NextCure jumps on short squeeze; biotech firms rise amid investigations.

T3 Defense surges 201% on tech expansion; NextCure jumps on short squeeze; biotech firms rise amid investigations.

T3 Defense's stock soared 201% following its subsidiary's expansion of defense technology into industrial materials, signaling strong growth potential. NextCure saw a 20.75% rise driven by a significant short squeeze, reflecting heavy short interest ...

Market News
Bullish
17 minutes ago
Environics Analytics appoints Cenker Ozhelvaci as Head of Sales to boost growth in Canada.

Environics Analytics appoints Cenker Ozhelvaci as Head of Sales to boost growth in Canada.

Environics Analytics has named Cenker Ozhelvaci as Head of Sales for its core direct sales teams. Ozhelvaci brings extensive experience from sectors like financial services and technology, having previously led sales at Provenir and Amazon Canada. Hi...

Market News
Bullish
35 minutes ago
AT&T beats earnings, announces $10B buyback, trades at 8x earnings with 4.6% yield.

AT&T beats earnings, announces $10B buyback, trades at 8x earnings with 4.6% yield.

AT&T reported better-than-expected earnings and announced a $10 billion share buyback program. Despite the positive results and buyback plan, the stock still trades at a relatively low valuation of 8 times earnings and offers a 4.6% dividend yield. T...

Company Fundamentals
Bullish
39 minutes ago
AstraZeneca's Q2 earnings jump 21% despite generic drug competition, beating estimates.

AstraZeneca's Q2 earnings jump 21% despite generic drug competition, beating estimates.

AstraZeneca reported a 21% increase in core earnings per share to $2.63 for Q2 2026, surpassing analyst expectations of $2.50. Total revenue rose 6% to $15.38 billion, driven by strong sales in oncology and rare disease drugs, offsetting pressure fro...

Company Fundamentals
Bullish
1 hour ago
American Tower's price targets fall despite strong Q1 growth and solid 2026 outlook.

American Tower's price targets fall despite strong Q1 growth and solid 2026 outlook.

American Tower Corporation's analyst price targets have dropped from $218.24 to $188 over the past year, reflecting cautious market sentiment. However, the company reported a robust 6.8% revenue growth in Q1 2026, driven by its international towers a...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App